Old Web
English
Sign In
Acemap
>
authorDetail
>
Will Harris
Will Harris
Genentech
Medicine
Atezolizumab
urothelial cancer
Immune system
Chemotherapy
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TRAIL (Tolerability of R-CHOP in Aggressive non-Hodgkin Lymphoma): A Predictive Algorithm to Support Clinical Decision-Making
2020
Blood
Edward Bataillard
Will Harris
Tarec Christoffer El-Galaly
Antonia Kwan
Carsten Henneges
Joseph N. Paulson
Tina Nielsen
Show All
Source
Cite
Save
Citations (0)
Tumor, immune, and stromal characteristics associated with clinical outcomes with atezolizumab (atezo) + platinum-based chemotherapy (PBC) or atezo monotherapy (mono) versus PBC in metastatic urothelial cancer (mUC) from the phase III IMvigor130 study.
2020
Journal of Clinical Oncology
Matthew D. Galsky
Romain Banchereau
Habib Rahman Hamidi
Ning Leng
Will Harris
Peter H. ODonnell
Edward E. Kadel
Kobe C. Yuen
D X Jin
Hartmut Koeppen
Darren Tayama
Enrique Grande
Jose Angel Arranz
Maria De Santis
Ian D. Davis
Eiji Kikuchi
Xiaodong Shen
Aristotelis Bamias
Sanjeev Mariathasan
Show All
Source
Cite
Save
Citations (12)
1